prikaz prve stranice dokumenta Metabolički sindrom - novi pristup u definiranju i liječenju
  Download
PDF 788.67 KB
Professional paper - Review paper
Metabolički sindrom - novi pristup u definiranju i liječenju
Farmaceutski glasnik, 69 (2013), 5; 333-345. urn:nbn:hr:163:229931
Šarić, Martina; Škunca, Monika; Ortner Hadžiabdić, Maja; Božikov, Velimir

Institutional repository: Repository of Faculty of Pharmacy and Biochemistry University of Zagreb

Cite this document

Šarić, M., Škunca, M., Ortner Hadžiabdić, M. & Božikov, V. (2013). Metabolički sindrom - novi pristup u definiranju i liječenju. Farmaceutski glasnik, 69. (5), 333-345. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:229931

Šarić, Martina, et al. "Metabolički sindrom - novi pristup u definiranju i liječenju." Farmaceutski glasnik, vol. 69, no. 5, 2013, pp. 333-345. https://urn.nsk.hr/urn:nbn:hr:163:229931

Šarić, Martina, Monika Škunca, Maja Ortner Hadžiabdić and Velimir Božikov. "Metabolički sindrom - novi pristup u definiranju i liječenju." Farmaceutski glasnik 69, no. 5 (2013): 333-345. https://urn.nsk.hr/urn:nbn:hr:163:229931

Šarić, M., et al. (2013) 'Metabolički sindrom - novi pristup u definiranju i liječenju', Farmaceutski glasnik, 69(5), pp. 333-345. Available at: https://urn.nsk.hr/urn:nbn:hr:163:229931 (Accessed 25 November 2024)

Šarić M, Škunca M, Ortner Hadžiabdić M, Božikov V. Metabolički sindrom - novi pristup u definiranju i liječenju. Farmaceutski glasnik [Internet]. 2013 [cited 2024 November 25];69(5):333-345. Available at: https://urn.nsk.hr/urn:nbn:hr:163:229931

M. Šarić, M. Škunca, M. Ortner Hadžiabdić and V. Božikov, "Metabolički sindrom - novi pristup u definiranju i liječenju", Farmaceutski glasnik, vol. 69, no. 5, pp. 333-345, 2013. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:229931. [Accessed: 25 November 2024]

Metadata
Title (croatian)Metabolički sindrom - novi pristup u definiranju i liječenju
AuthorMartina Šarić
AuthorMonika Škunca
AuthorMaja Ortner Hadžiabdić
AuthorVelimir Božikov
Author's institutionUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Centre for applied pharmacy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Pharmacy
Abstract (english)
Metabolic syndrome (MS) is a combination of medical disorders that, when occuring together, increase the risk of developing cardiovascular disease and diabetes. Its prevalence has increased and it has become a significant public health issue around the world. The definition of MS varies among different organisations. The consensus has been made among the two most influential definitions (IDF and NCEP/ATPIII), and the diagnosis of MS could be established if any three of five factors were present;these are abdominal obesity measured as waist circumference, elevated triglycerides, reduced HDL-C, elevated blood pressure, and elevated fasting glucose. Management of MS focuses on recognizing patients with MS and introducing measures to decrease their risk factors. Primary recommendations are lifestyle changes (healthy diet and physical activity), but pharmacology treatment (i.e. antihypertensive, antidiabetic, antihyperlipidemic) for specific condition is indicated if lifestyle changes were not effective and did not result in the recommended goals. The role of the pharmacist is very important in identifying patients with MS, educating patients about lifestyle changes, monitoring the progress and referral to other healthcare providers, if needed.
Keywords (croatian)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review - domestic
Publication versionPublished version
Journal titleFarmaceutski glasnik
Numberingvol. 69, no. 5, pp. 333-345
p-ISSN0014-8202
URN:NBNurn:nbn:hr:163:229931
Publication2013
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2020-09-30 13:30:54